Organized by Drs. Danielle Swaney and Chris Adams, the 2024 QBI-Rezo Therapeutics Mass Spectrometry Symposium will be held at UCSF Mission Bay on May 30, 2024.

Under the leadership of Dr. Nevan Krogan, the Quantitative Biosciences Institute (QBI) seeks transformative results in biomedicine by supporting fundamental quantitative research in the biological sciences. In support of this mission, the symposium will focus on emerging proteomic technologies to address outstanding biological challenges.

Confirmed Speakers:

Keriann Backus, UC Los Angeles

Katherine Donovan, Dana-Farber Cancer Institute

Ruth Huttenhain, Stanford University

Susan Klaeger, Genentech Inc.

Manuel Leonetti, CZ Biohub

Yansheng Liu, Yale University

Jesper Olsen, University of Copenhagen

Nick Riley, University of Washington

Matt Rardin, Amgen

Emma Lundberg, Stanford